Please try another search
Fuji Pharma Co., Ltd. engages in the research and development, manufacture, and marketing of pharmaceutical products in Japan and internationally. The company offers injection agents, internal drugs, drugs for external use, and diagnostic products. It also provides medical care for women, in vitro diagnostics, acute medical care products, and curative medicines, as well as information regarding pharmaceuticals and health; and contract manufacturing services. Fuji Pharma Co., Ltd. was incorporated in 1965 and is headquartered in Tokyo, Japan.
Name | Age | Since | Title |
---|---|---|---|
Hirofumi Imai | 59 | 1998 | Chairman |
Toyoyuki Kamide | 58 | 2007 | VP, Executive Officer & Director |
Fujiaki Mimura | 70 | 2003 | Outside Audit & Supervisory Board Member |
Miori Sagara | - | - | Outside Audit & Supervisory Board Member |
Keiji Hirai | 75 | 2016 | Independent Outside Director |
Minesaburo Miyake | 72 | 2017 | Independent Outside Director |
Syuhei Morita | 50 | 2023 | Director |
Yukiko Araki | 64 | 2020 | Independent Outside Director |
Keiko Kiyama | 64 | 2020 | Independent Outside Director |
Satoshi Suzuki | 61 | 2022 | Vice President & Director |
Daiji Ojima | 60 | 2023 | Audit & Supervisory Board Chairman |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review